Jeremy Braybrooke - Nuffield Department of Population Health, Medical Sciences Division, University of Oxford;University of Bristol

基本信息

Career Trajectory

Bio

Jeremy has developed a large research focussed clinical practice specialising in breast and testicular cancers. Jeremy sits on a NICE Technology Appraisal Committee evaluating new medicines and is a member of the Royal College of Physicians Specialist Advisory Committee for medical oncology training. He is actively involved in clinical research and since 2016 has worked part time as a Senior Clinical Research Fellow within EBCTCG.

Research Interests

Papers共 118 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The PARTNER Trial of Neoadjuvant Olaparib with Chemotherapy in Triple-Negative Breast Cancer

Jean E. Abraham,Karen Pinilla,Alimu Dayimu,Louise Grybowicz,Nikolaos Demiris,Caron Harvey,Lynsey M. Drewett,Rebecca Lucey, Alexander Fulton,Anne N. Roberts, Joanna R. Worley,Anita Chhabra,Wendi Qian,Anne-Laure Vallier,Richard M. Hardy,Steve Chan,Tamas Hickish, Devashish Tripathi,Ramachandran Venkitaraman,Mojca Persic,Shahzeena Aslam, Daniel Glassman,Sanjay Raj,Annabel Borley,Jeremy P. Braybrooke,Stephanie Sutherland, Emma Staples, Lucy C. Scott, Mark Davies, Cheryl A. Palmer, Margaret Moody,Mark J. Churn, Jacqueline C. Newby,Mukesh B. Mukesh, Amitabha Chakrabarti,Rebecca R. Roylance,Philip C. Schouten, Nicola C. Levitt,Karen Mcadam,Anne C. Armstrong,Ellen R. Copson,Emma Mcmurtry,Marc Tischkowitz,Elena Provenzano,Helena M. Earl

NATURE（2024）

Cited0Views0WOSNATUREBibtex

Abstract CT012: PARTNER Trial: Neoadjuvant Olaparib in Triple Negative Breast Cancer (TNBC)

Jean E. Abraham,Karen Pinilla,Louise Grybowicz,Alimu Dayimu,Nikolaos Demiris,Caron Harvey,Lynsey M. Drewett,Rebecca Lucey, Alexander Fulton,Anne N. Roberts, Joanna R. Worley,Anita Chhabra,Wendi Qian,Richard M. Hardy,Stephen Chan,Tamas Hickish, Devashish Tripathi,Ramachandran Venkitaraman,Mojca Persic,Shahzeena Aslam, Daniel Glassman,Sanjay Raj,Annabel Borley,Jeremy P. Braybrooke,Stephanie Sutherland, Emma Staples, Lucy C. Scott, Mark Davies, Cheryl A. Palmer, Margaret Moody,Mark J. Churn, Jacqueline C. Newby,Mukesh B. Mukesh, Amitabha Chakrabarti,Rebecca R. Roylance,Philip C. Schouten,Nicola Levitt,Karen McAdam,Anne C. Armstrong,Ellen R. Copson,Emma McMurtry,Marc Tischkowitz,Elena Provenzano,Helena Earl

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Expert UK Consensus on the Definition of High Risk of Recurrence in HER2-negative Early Breast Cancer: A Modified Delphi Panel

E. R. Copson,J. E. Abraham,J. P. Braybrooke, D. Cameron,S. A. Mcintosh, C. O. Michie,A. F. C. Okines,C. Palmieri,F. Raja,R. Roylance

Breast (2023): 103582-103582

Cited0Views0WOSBibtex

Radiotherapy to Regional Nodes in Early Breast Cancer: an Individual Patient Data Meta-Analysis of 14 324 Women in 16 Trials

Carolyn Taylor,David Dodwell,Paul McGale, Robert K. Hills, Richard Berry, Rosie Bradley,Jeremy Braybrooke, Mike Clarke,Richard Gray, Francesca Holt, Zulian Liu,Hongchao Pan,Richard Peto, Ewan Straiton,Jonas Bergh, Charlotte Coles, Fran Duane,Christophe Hennequin, Glenn Jones, Thorsten Kuehn, Sileida Oliveros,Jens Overgaard, Kathy Pritchard,Chang-Ok Suh,Sandra Swain, Tim Whelan,Philip Poortmans

Lancetno. 10416 (2023): 1991-2003

Cited1Views0WOSBibtex

Effects of Ovarian Ablation or Suppression on Breast Cancer Recurrence and Survival: Patient-level Meta-Analysis of 14,993 Pre-Menopausal Women in 25 Randomized Trials

Richard G. Gray,Rosie Bradley,Jeremy Braybrooke,Mike Clarke,Robert Kerrin Hills,Richard Peto,Jonas C. S. Bergh,Sandra M. Swain,Nancy E. Davidson,Prudence A. Francis,Meredith M. Regan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

Cited2Views0Bibtex

Abstract P3-05-39: Expert Consensus on the Definition of High Risk of Recurrence in HER2-negative Early Breast Cancer: a Modified Delphi Panel

Ellen R. Copson,Jean E. Abraham,Jeremy P. Braybrooke,Stuart A. McIntosh,Caroline O. Michie,Carlo Palmieri,Rebecca Roylance, Saiqa Spensley

Cancer Researchno. 5_Supplement (2023): P3-05

Cited0Views0Bibtex

Anthracycline-containing and Taxane-Containing Chemotherapy for Early-Stage Operable Breast Cancer: a Patient-Level Meta-Analysis of 100 000 Women from 86 Randomised Trials

Jeremy Braybrooke,Rosie Bradley, Richard Gray,Robert K. Hills,Hongchao Pan,Richard Peto,David Dodwell,Paul McGale,Carolyn Taylor,Tomohiko Aihara,Stewart Anderson,Greg Yothers,Joanne Blum, Joyce O'Shaughnessy,Fatima Cardoso, Xiaosong Chen,John Crown,Bent Ejlertsen,Maj-Britt Jensen,Thomas W. P. Friedl,Wolfgang Janni, N. Harbeck,Eleftherios Mamounas, K. Narui, Ulrike Nitz, Larry Norton,Martine Piccart,Nicholas Robert,Zhi-Ming Shao,Ke-Da Yu,Dennis Slamon,Joseph Sparano, Toru Watanabe,Jonas Bergh,Sandra Swain, R. Berry,C. Boddington, R. Bradley, M. Clarke, C. Davies, L. Davies, D. Dodwell,F. Duane, V. Evans, J. Gay,L. Gettins, J. Godwin, R. Gray,R. K. Hills, S. James, H. Liu, Z. Liu,E. MacKinnon,G. Mannu,P. McGale, T. McHugh, P. Morris, M. Nakahara, H. Pan, R. Peto, S. Read, E. Straiton, C. Taylor

Lancetno. 10384 (2023): 1277-1292

Cited10Views0WOSBibtex

Aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor positive early stage breast cancer treated with ovarian suppression: A patient level meta-analysis of 7,030 women in four randomised trials

Rosie Bradley,Jeremy Braybrooke,Richard Gray,Robert K. Hills,Zulian Lui,Hongchao Pan,Richard Peto,Jonas Bergh,Sandra M. Swain,Prudence Francis,Michael Gnant, Francesco Perrone,Meredith M. Regan

CANCER RESEARCHno. 4 (2022)

Cited67Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn